Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06529198Not ApplicableNot Yet Recruiting

NeuroGyn Genital Neuromodulation System for iOAB Treatment

Role: lead

NCT05231083Not ApplicableUnknown

Genital Nerves Stimulation for Treatment for Erectile Dysfunction

Role: lead

NCT04160793Not ApplicableUnknown

Genital Nerve Stimulation - GNS - for Treatment of Non-neurogenic OAB

Role: lead

All 3 trials loaded